Multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multiple myeloma

Published:2017-07-20 Issue:1 Volume:3 Page:
ISSN:2056-676X
Container-title:Nature Reviews Disease Primers
language:en
Short-container-title:Nat Rev Dis Primers

Author:

Kumar Shaji K.,Rajkumar Vincent,Kyle Robert A.,van Duin Mark,Sonneveld Pieter,Mateos María-Victoria,Gay Francesca,Anderson Kenneth C.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://www.nature.com/articles/nrdp201746.pdf

Reference164 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7–30 (2016).

2. Gonsalves, W. I. et al. Prognostic significance of quantifying circillating plasma cells in multiple myeloma. Clin. Lymphoma Myeloma Leuk. 14, S147 (2014).

3. Drayson, M. et al. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 97, 2900–2902 (2001).

4. Kyle, R. A. et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin. Proc. 78, 21–33 (2003).

5. Rajkumar, S. V. et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15, e538–e548 (2014). This is the current diagnostic criteria for multiple myeloma and related disorders.

Cited by 849 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced tumor organoid bioprinting strategy for oncology research;Materials Today Bio;2024-10

2. Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma;Bioorganic & Medicinal Chemistry;2024-09

3. Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence;Frontiers in Oncology;2024-08-30

4. Prognostic factors and clinical characteristics of patients with newly diagnosed non-secretory multiple myeloma in the era of new drugs in “real-world” study: Experiences of the Polish Myeloma Group;Advances in Clinical and Experimental Medicine;2024-08-29

5. CAR-T cell therapy in relapsed or refractory multiple myeloma and access in Turkey;Frontiers in Medicine;2024-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3